ALKBH5 and non-small cell lung carcinoma: In NSCLC cells, reduced distribution of ALKBH5 in the nucleus results in increased m6A modification of SOCS2 and reduced expression of SOCS2, which stimulates the JAK‐STAT pathway and promotes the NSCLC progression.